Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Potassium hydroxide (KOH) is a strong inorganic base used in dermatology as a topical keratolytic and caustic agent. It is primarily utilized in aqueous solutions at concentrations ranging from 5% to 15% for the treatment of molluscum contagiosum, where it induces localized tissue destruction and an inflammatory response that facilitates viral clearance. More recently, it has been investigated for the treatment of actinic keratosis (AK), where its ability to dissolve keratin and cause controlled chemical irritation helps eliminate dysplastic keratinocytes. In many European jurisdictions, these topical solutions are regulated as medical devices due to their physical-chemical mode of action rather than a pharmacological mechanism.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on potassium hydroxide.